Skip to Main Content

Paper Details

Informing selection of drugs for COVID-19 treatment through adverse events analysis.
Sci Rep
5
2021
COVID-19, Coronavirus disease 2019, SOCs, patients
Author NameAffiliation
Weida TongNational Center for Toxicological Research
Weida TongNational Center for Toxicological Research
Huixiao HongNational Center for Toxicological Research
  • 1 - 3

Datasets

Release 1.2